Cargando…

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?

Epidemiological and modelling studies suggest that elimination of Onchocerca volvulus transmission (EoT) throughout Africa may not be achievable with annual mass drug administration (MDA) of ivermectin alone, particularly in areas of high endemicity and vector density. Single-dose Phase II and III c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kura, Klodeta, Milton, Philip, Hamley, Jonathan I. D., Walker, Martin, Bakajika, Didier K., Kanza, Eric M., Opoku, Nicholas O., Howard, Hayford, Nigo, Maurice M., Asare, Sampson, Olipoh, George, Attah, Simon K., Mambandu, Germain L., Kennedy, Kambale Kasonia, Kataliko, Kambale, Mumbere, Mupenzi, Halleux, Christine M., Hopkins, Adrian, Kuesel, Annette C., Kinrade, Sally, Basáñez, Maria-Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440165/ https://www.ncbi.nlm.nih.gov/pubmed/37598705 http://dx.doi.org/10.1098/rstb.2022.0277

Ejemplares similares

Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection
por: Bakajika, Didier, et al.
Publicado: (2022)

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial
por: Opoku, Nicholas O, et al.
Publicado: (2018)

The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
por: Turner, Hugo C, et al.
Publicado: (2015)

Sirenomelia associated with an anterior abdominal wall defect: a case report
por: Kavunga, Eric Kambale, et al.
Publicado: (2019)

Huge scalp Morel-Lavallée lesion with eye involvement in a 3-year-old girl: a case report
por: Masumbuko, Claude Kasereka, et al.
Publicado: (2021)

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection
por: Tan, Beesan, et al.
Publicado: (2022)

A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection
por: Awadzi, Kwablah, et al.
Publicado: (2014)

Onchocerciasis Elimination: Progress and Challenges
por: Lakwo, Thomson, et al.
Publicado: (2020)

Research for new drugs for elimination of onchocerciasis in Africa
por: Kuesel, Annette C.
Publicado: (2016)

Newborn screening for sickle cell disease in Butembo and Beni: a pilot experience in a highland region of the Democratic Republic of Congo
por: Mumbere, Mupenzi, et al.
Publicado: (2023)

Antimicrobial resistance in a war-torn country: Lessons learned in the Eastern Democratic Republic of the Congo
por: Bunduki, Gabriel Kambale, et al.
Publicado: (2019)

Alternative treatment strategies to accelerate the elimination of onchocerciasis
por: Boussinesq, Michel, et al.
Publicado: (2018)

Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs
por: Hamley, Jonathan I. D., et al.
Publicado: (2019)

Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring
por: Hamley, Jonathan I D, et al.
Publicado: (2020)

Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making
por: Stolk, Wilma A, et al.
Publicado: (2021)

Evaluation of the Cardiac Safety of Long‐Acting Endectocide Moxidectin in a Randomized Concentration‐QT Study
por: Kinrade, Sally A., et al.
Publicado: (2018)

Solvatomorphism of Moxidectin
por: Grell, Toni, et al.
Publicado: (2021)

What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
por: Hamley, Jonathan I D, et al.
Publicado: (2021)

Early Experiences in the Integration of Non-communicable Diseases into Emergency Primary Health Care, Beni Region, Democratic Republic of the Congo
por: Ratnayake, Ruwan, et al.
Publicado: (2021)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
por: Colebunders, Robert, et al.
Publicado: (2022)

One month follow up of a neonate born to a mother who survived Ebola virus disease during pregnancy: a case report in the Democratic Republic of Congo
por: Baraka, N. Kasereka, et al.
Publicado: (2019)

Late abdominal pregnancy in a post-conflict context: case of a mistaken acute abdomen - a case report
por: Paluku, Justin Lussy, et al.
Publicado: (2020)

“Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013”
por: Lakwo, Thomson, et al.
Publicado: (2018)

Demographic patterns of human antibody levels to Simulium damnosum s.l. saliva in onchocerciasis-endemic areas: An indicator of exposure to vector bites
por: Willen, Laura, et al.
Publicado: (2022)

Response to the Letter to the Editor by Eberhard et al.
por: Bottomley, Christian, et al.
Publicado: (2017)

Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings
por: Bottomley, Christian, et al.
Publicado: (2016)

Ebola in the Eastern Democratic Republic of Congo: One Health approach to infectious disease control
por: Sikakulya, Franck katembo, et al.
Publicado: (2019)

Supporting Drug Development for Neglected Tropical Diseases Using Mathematical Modeling
por: Walker, Martin, et al.
Publicado: (2021)

Management of severe acute malnutrition by cow milk in resource constraints settings: experience of the Nutritional Centre of the University Clinics of Graben
por: Mumbere, Mupenzi, et al.
Publicado: (2018)

A Game-Theoretical Winner and Loser Model of Dominance Hierarchy Formation
por: Kura, Klodeta, et al.
Publicado: (2016)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

Synophtalmia on a newborn
por: Bihamba Bira, Laetitia, et al.
Publicado: (2022)

Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch
por: Awadzi, K., et al.
Publicado: (2015)

Fine needle aspiration-induced vascular proliferation of the thyroid: A report of two cases
por: Ramraje, Sushma N., et al.
Publicado: (2012)

Identification of the onchocerciasis vector in the Kakoi-Koda focus of the Democratic Republic of Congo
por: Post, Rory J., et al.
Publicado: (2022)

Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme
por: Turner, Hugo C., et al.
Publicado: (2015)

Onchocerciasis
Publicado: (1911)

Economic evaluations of onchocerciasis interventions: a systematic review and research needs
por: Turner, Hugo C., et al.
Publicado: (2019)

Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
por: Kura, Klodeta, et al.
Publicado: (2022)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ul76rdq15isj6vjvnpssr4os2h